Health and Healthcare

Abbott Laboratories : ABT

All Abbott Laboratories Articles

321 Articles

Paul Ausick | Jul 18, 2012 at 10:56 AM EDT

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…

Paul Ausick | Jul 18, 2012 at 8:34 AM EDT

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…

Paul Ausick | Jul 17, 2012 at 4:03 PM EDT

24/7 Wall St. Closing Bell — July 17, 2012: Markets Higher After Bernanke Speaks

The three major US stock indexes opened higher this morning in advance of Fed Chairman Ben Bernanke’s semi-annual report to…

Jon C. Ogg | Jul 17, 2012 at 2:17 PM EDT

10 Key Earnings Previews For Wednesday (ABT, AXP, BAC, DAL, EBAY, HON, IBM, QCOM, USB, YUM)

Wednesday is going to mark yet another important day for the early wave of key earnings for this earnings season. …

Jon C. Ogg | Apr 4, 2012 at 1:28 PM EDT

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment…

Paul Ausick | Mar 8, 2012 at 1:49 PM EST

Abbott Labs Posts New High on FDA Approval (ABT)

Health care products maker Abbott Laboratories (NYSE: ABT) received US Food and Drug Administration approval to market its new glucose…

Jon C. Ogg | Jan 25, 2012 at 7:58 AM EST

Abbott Earnings Beat As Sales Growth Lags (ABT)

Abbott Laboratories (NYSE: ABT) may be in the midst of a long-term restructuring, but the company turned in earnings growth…

Douglas A. McIntyre | Jan 6, 2012 at 6:39 AM EST

Short Sellers Help Push Dendreon Higher

Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that…

Douglas A. McIntyre | Oct 20, 2011 at 4:15 AM EDT

America’s Most Overpaid CEOs

It’s that time of year again, when proxies are released and many business publications run lists of the highest paid…

Paul Ausick | Oct 19, 2011 at 4:20 PM EDT

24/7 Wall St. Closing Bell (AAPL, WMT, WFM, MS, BAC, INTC, WMB, HGSI, ABT, OXGN, PWAV, AEM)

Stocks opened down this morning following the earnings report Apple Inc. (NASDAQ: AAPL) after markets closed yesterday. Moody’s downgrade of Spain’s…

Jon C. Ogg | Oct 19, 2011 at 10:18 AM EDT

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public. So what…

Douglas A. McIntyre | Oct 19, 2011 at 8:50 AM EDT

The Twitter-24/7 Wall St. Market Report (10/19/2011) Abbott Lab Splits, Morgan Earnings

MSNBC: US housing starts jumped in September http://on.msnbc.com/pxVyNE NYT: Olympus Backtracks on Payments http://nyti.ms/pAPNmD CNNMoney: Apple 2.0: Apple’s big miss:…

Douglas A. McIntyre | Oct 6, 2011 at 7:27 PM EDT

America’s Recession-Proof Companies

With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there…

Jon C. Ogg | Sep 14, 2011 at 8:01 AM EDT

Boston Scientific Gets New Boss, Eventually (BSX, JNJ, ABT)

Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th…

Douglas A. McIntyre | Jul 18, 2011 at 8:02 PM EDT

The Eleven Most Implanted Medical Devices In America

Implanted medical devices are one of the most profitable businesses of the U.S. healthcare industry. While many devices help extend…

1 … 13 14 15 16 17 … 22

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

24/7 Wall St. Closing Bell — July 17, 2012: Markets Higher After Bernanke Speaks

10 Key Earnings Previews For Wednesday (ABT, AXP, BAC, DAL, EBAY, HON, IBM, QCOM, USB, YUM)

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

Abbott Labs Posts New High on FDA Approval (ABT)

Abbott Earnings Beat As Sales Growth Lags (ABT)

Short Sellers Help Push Dendreon Higher

America’s Most Overpaid CEOs

24/7 Wall St. Closing Bell (AAPL, WMT, WFM, MS, BAC, INTC, WMB, HGSI, ABT, OXGN, PWAV, AEM)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

The Twitter-24/7 Wall St. Market Report (10/19/2011) Abbott Lab Splits, Morgan Earnings

America’s Recession-Proof Companies

Boston Scientific Gets New Boss, Eventually (BSX, JNJ, ABT)

The Eleven Most Implanted Medical Devices In America

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

24/7 Wall St. Closing Bell — July 17, 2012: Markets Higher After Bernanke Speaks

10 Key Earnings Previews For Wednesday (ABT, AXP, BAC, DAL, EBAY, HON, IBM, QCOM, USB, YUM)

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

Abbott Labs Posts New High on FDA Approval (ABT)

Abbott Earnings Beat As Sales Growth Lags (ABT)

Short Sellers Help Push Dendreon Higher

America’s Most Overpaid CEOs

24/7 Wall St. Closing Bell (AAPL, WMT, WFM, MS, BAC, INTC, WMB, HGSI, ABT, OXGN, PWAV, AEM)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

The Twitter-24/7 Wall St. Market Report (10/19/2011) Abbott Lab Splits, Morgan Earnings

America’s Recession-Proof Companies

Boston Scientific Gets New Boss, Eventually (BSX, JNJ, ABT)

The Eleven Most Implanted Medical Devices In America

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Most People Don’t Get to Pick Their Last Day of Work. These 4 ETFs Make Sure the Money Is Ready When It Comes

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income